Raman PuriI P Apollo Hospital;Lipid Association of India, India
Title: Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India
An estimated 74 million individuals in India had diabetes in 2021, almost all of them type 2. The prevalence of undiagnosed diabetes is more than half, and dyslipidemia is associated with the accelerated development of atherosclerotic cardiovascular disease (ASCVD) in more than 90% of patients with diabetes. Multiple features distinguish Indian patients with diabetes from those with diabetes in Western populations. These characteristics include earlier onset, more frequent metabolic syndrome features, more prevalent risk factors for ASCVD, and a more aggressive course of ASCVD complications. The Lipid Association of India developed this expert consensus statement to provide guidance on the management of diabetic dyslipidemia in this very high-risk population given the unique characteristics of diabetes and diabetic dyslipidemia among Indians. This document is the result of 165 webinars conducted by the Lipid Association of India across the country from May 2020 to July 2021, involving 155 endocrinologists and cardiologists and an additional 2880 physicians. The Lipid Association of India proposed an algorithm for treating diabetic dyslipidemia in their recently published document in Journal of Clinical Lipidology.
Raman Puri is the founder and chairman of the Lipid Association of India. He is a senior interventional cardiologist at the Cardiac Care Centre, in New Delhi. He is visiting an interventional cardiologist at Apollo Hospital in Delhi. Also he is a former head of department of cardiology, Safdarjung Hospital, New Delhi. He is a member of the International Lipid Expert Panel and IAS Regional Federation: Asia Pacific.